Chen David, Bowersock Terry, Weeratna Risini, Yeoh Thean
Novel Delivery Technologies, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, USA.
Global Biologics Research, Zoetis Inc., Kalamazoo, MI, USA.
Ther Deliv. 2015;6(9):1101-8. doi: 10.4155/tde.15.65. Epub 2015 Oct 12.
The skin is an attractive site for immunization in humans and animals, owing to its resident population of dendritic cells and macrophages along with extensive vascularization by lymphatic vessels and blood capillaries. In addition to these physiological attributes, the intradermal route for vaccine delivery also presents a less-invasive alternative to conventional subcutaneous or intramuscular injections. This may offer compliance and convenience advantages for a wide range of stakeholders including patients, healthcare providers, veterinarians, animal owners and animal producers. This review discusses the current developments in intradermal vaccination for human and veterinary applications, with particular focus on the skin immunology, vaccine antigens and adjuvants and delivery systems.
由于皮肤中存在树突状细胞和巨噬细胞,以及丰富的淋巴管和毛细血管血管化,因此皮肤是人类和动物免疫接种的理想部位。除了这些生理特性外,皮内注射疫苗的途径也是传统皮下或肌肉注射的一种侵入性较小的替代方法。这可能为包括患者、医疗保健提供者、兽医、动物主人和动物生产者在内的广泛利益相关者带来依从性和便利性优势。本综述讨论了人皮内疫苗接种和兽用皮内疫苗接种的当前进展,特别关注皮肤免疫学、疫苗抗原和佐剂以及递送系统。